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INTRODUCTION
Previously it was reported that ovaries of host
mice transplanted subcutaneously with melatonin
treatment preserved endocrine functions as well as
promoted the quality of the follicle in the ovarian
graft [9–11]. This technique can be used to mini-
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This study was conducted to assess the effect of melatonin on the structure of
testis and spermatogenesis dynamics in neonate vitrified testis grafts. Neonate
vitrified testes, candidates for transplantation heterotopically to experiment or control
groups, were warmed in thawing media which had or did not have a supplement
of 100 µM melatonin, respectively. Following transplantation, melatonin (20 mg/
/kg/day) or saline solution was intraperitoneally injected into the treated and the
non-treated groups, respectively. The initiating spermatogenesis, spermatogonia
survival, and structure of tissue in the testis graft were examined. Cell apoptosis
(TUNEL assay) and proliferation (Brdu assay) in germ cells were determined.
Histological studies revealed the dynamic of the spermatogenesis process in the
vitrified testis graft. However, dilation of the lumen accompanied by a disorganised
epithelium in the non-treated group was higher than in the treated group. Further-
more, the proportion of apoptotic germ cells together with a reduced proportion of
proliferated germ cells was higher in the non-treated group than in the treated
group. Overall, the number of seminiferous tubules in the testes grafts of both groups
remained steady. However, the non-treated testes grafts contained more damaged
seminiferous tubules than the treated ones. The thickness of the seminiferous tu-
bules was greater in the melatonin treated group than in the non-treated group. In
fact, the thickness of germinal epithelium was significantly higher in the treated
group than in the non-treated group. The study may show a positive effect from
melatonin resulting in more grafts restoring puberty. Furthermore, the associated
increase in the healthy number of seminiferous tubules suggests that melatonin may
have a preventative ischaemia/antioxidant role and in fact may be useful to initiate
the spermatogenesis process. (Folia Morphol 2011; 70, 2: 95–102)
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mise the impaired function of the testis graft as well.
Similar to ovarian tissue, testicular banking offers
the possibility of fertility and endocrine function con-
servation if the testis is successfully transplanted [14,
26]. Important progress in minimising the unwant-
ed side effects of transplantation has been achieved
by constantly modifying and optimising the revas-
cularisation of the graft. However, revascularisation
more than 48 hours after grafting [12] is consi-
dered a major obstacle for tissue transplantation due
to the loss of a huge part of the tissue during the
initial ischaemia [22]. In addition, it was shown that
freezing and thawing tissue before transplanting
adds additional metabolic stress [8], which indicates
that tissue loss is partly due to reactive oxygen spe-
cies generated during the hypoxic condition due to
some clinical disorders such as ischaemia and reper-
fusion [2]. Therefore, proper steps should be taken
to choose a new avenue based on using antioxidants
that can be applied to minimise lipid peroxidation
in transplant tissue. Melatonin is produced essen-
tially by the pineal gland and is supposed to have
free radical scavenger properties [16]. The effects of
melatonin on the testis organ and sex hormone syn-
thesis have also been tested in experiments on ani-
mals [1]. Since melatonin receptors were found in
the reproductive systems of different species, it
seems reasonable to assume that melatonin may
exert its antioxidant effects via direct interaction with
the steroidogenic cells of the reproductive tissue [4].
To our knowledge, there has been no research re-
garding the effects of melatonin regimen to evalu-
ate putative antioxidant activity of melatonin dur-
ing transplantation. However, a changed neuroen-
docrine gonadal axis in males was reported in the
experimental study [19]. Seethalakshmi et al. [20]
showed that the weight of the testis, sperm count,
and motility are declined in grafted testes. More-
over, Cameron et al. [5] reported that the tubule
wall thickness, germ cell depletion, and sertoli cell
vacuolisation increased in testicular grafts.
Enhanced oxidative stress and changes in anti-
oxidant capacity play critical roles in the pathogen-
esis of testis transplantation [21, 23]. Although the
underlying mechanisms of the alterations associat-
ed with testis transplantation are presently not well
understood, hypoxia can lead to increased oxida-
tive stress due to the enhancement of the produc-
tion of several reducing glucoses (during glycolysis
and the polyol pathway) [3, 15].
Ultimately, the aim of the present study was to
assess the effects of melatonin on mouse testicular




Melatonin (Helsinn Advanced Synthesis SA, Bia-
sca and Sigma Chemicals, Buchs, Switzerland) was
used for intraperitoneal injection.
Animals
The experiments were carried out in accordance
with the Tehran University Guide for the Care and
Use of Laboratory Animals. Six-day-old male (CBA
× C57Bl/6) F1 hybrid mice (n = 162) were used as
testis donors and 10–12-week-old males of the same
strain were used as testis recipients (n = 108) (Pas-
ture Institute of Iran). Recipient mice were random-
ly assigned either to control (group I) or treated
groups (group II). Group I received daily physiolo-
gical saline and Group II received melatonin (20 mg/
/kg/day), intraperitoneally. Each group was randomly
further distributed into nine subgroups (n = 6) that
were sacrificed at weeks 1–9.
Testis vitrification
The cryoprotectant solution was 40% (v/v) ethylene
glycol (Sigma, USA) containing 0.9% normal saline and
0.5 M raffinose. The vitrification solution (VS) was di-
luted with DPBS to make 12.5%, 25%, and 50% (v/v)
solutions. Intact testes of six-day-old mice were exposed
sequentially to 12.5% and 25% VS at room tempera-
ture for 5 min. Subsequently, they were exposed to 50%
VS for 15 min at 4°C. Then the testes were transferred
to 1.8 mL cryogenic vials (Nunc, Roskilde, Denmark) con-
taining 100% VS and placed directly into liquid nitro-
gen at –196°C. Before transplanting, cryogenic vials were
warmed up in 4°C water until the VS became liquid;
1 mL of cooled 50% VS was added into each cryogenic
vial. The testes were removed from the cryovials and
placed sequentially in solutions containing 50% and
25% VS concentrations at 4°C for 10 min and finally
were transferred successively in 12.5% VS and DPBS at
room temperature for 10 min.
Melatonin treatment in vitro
The thawed testes were further incubated for
30 min in aMEM plus 10% FBS, with or without
100 µM additive melatonin before being transplant-
ed subcutaneously onto the backs of the castrated
recipient mice of the treatment (group II) or non-
-treatment (group I) groups, respectively.
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Transplantation procedure
The host mice were sedated by intraperitoneal
injection of ketamine-xylazine mixture (Ketamine
80 mg/kg and Xylazine 10 mg/kg body weight; Phar-
macia & Upjohn, Erlangen, Germany). Testectomy
was performed and the intact vitrified-thawed tes-
tes were subsequently inserted bilaterally into the
subcutaneous site on the back of the recipient mice.
The time interval between removal and transplan-
tation was less than 1 min.
Melatonin treatment in vivo
Melatonin at 20 mg/kg/day was injected intra-
peritoneally into the mice once a day at 18:00 h (1 h
before initiation of a 12 h dark phase) throughout
the examined days after transplantation.
Histology staining
Samples were placed overnight in 4% buffered
formaldehyde (37% formaldehyde, Merck). Fixed tis-
sues were embedded in paraffin blocks and the whole
testis was sectioned serially at 4-mm thickness.
Assessment of apoptosis using TUNEL assay
Apoptosis was assessed by terminal deoxynu-
cleotidyl transferase (TdT) mediated deoxyuridine tripho-
sphate-biotin nick-end labelling (In Situ Cell Death
Detection Kit, Roche, Manheim, Germany), accord-
ing to the manufacturer’s instructions. Briefly, after
deparaffinisation and rehydration, sections were
incubated in 3% H2O2 (Merck) for 10 min to neutra-
lise endogenous peroxidases and then digested by
20 mg/mL proteinase K in 10 mM Tris-HCl (Roche)
for 30 min at room temperature. The sections were
then incubated with TdT for 1 h at 37°C followed by
incubation with anti digoxigenin peroxidase antibod-
ies. Control tissue samples were incubated using PBS
for the primary antibody. Apoptotic cells were ob-
served by staining with 3, 3-diaminobenzidine (DAB)
solutions (Sigma, Aldrich, USA). The samples were
counterstained with haematoxylin, rinsed with dis-
tilled water, dehydrated, mounted with entellan
(Merck, Germany), and observed with a light micro-
scope.
Assessment of proliferative capacity in vitrified-
-thawed testis graft, using in vivo BrdU assay
For tagging of the proliferating cells, 5-bromo-
-2-deoxyuridine (BrdU; 100 mg/kg body weight; Sig-
ma Aldrich, USA) was infused into the peritoneal
cavity 2 h before sacrificing the host mice. Tissue
samples were stained for Brdu (Brdu Cell Prolifera-
tion Kit; Chemicon). Briefly, the sections were de-
waxed, rehydrated, and rinsed in deionised water.
Endogenous peroxidase activity was quenched with
a 10-min incubation in 3% (v/v) H2O2 at room tem-
perature. After that, the samples were incubated
with horseradish peroxide (HRP)-conjugated mouse
monoclonal anti-Brdu antibody for 1 h at room tem-
perature and rinsed with PBS. Then, the samples
were incubated with peroxidase-conjugated goat
anti-mouse IgG for 1 h at room temperature. Con-
trol samples were incubated using PBS for the pri-
mary antibody. Proliferated cells were observed by
staining with DAB substrate. The samples were coun-
terstained with haematoxylin, rinsed with distilled
water, dehydrated, mounted with entellan, and
observed with a light microscope.
Morphometric analysis of the grafts
Histological were assessed by light microscopy.
The examined sections (approximately every 10th se-
ction) that were photographed were scored using
NIH Image software. Additionally, the following
parameters were determined for each graft: gene-
ral graft shape (fibrosis, fatty tissue, presence of se-
miniferous tubules), seminiferous tubule, germinal
epithelium thickness and most advanced germ cell
type present in each tubule. The tubular thickness
was also determined on micrographs using the NIH
Image software. One section per graft was used and,
if present, at least 50 tubule cross-sections were
evaluated. All the transplant samples were looked
at and assessed blindly by the same observer.
Statistical analysis
All data were expressed as mean ± S.E.M. The
paired sample t-test was employed to compare the
average testis weights of the melatonin-treated vs
non-treated groups, and to compare the average
number of grafts recovered from each group. Quan-
titative results obtained from the two groups were
assessed for statistical differences by one-way ana-
lysis of variance (ANOVA). Multiple comparison tests
(Tukey test) were employed to compare data from
all groups. P £ 0.05 was considered as significant.
RESULTS
Survival of the testis graft
Nine weeks after vitrified tissue transplanting,
22.2% (8/36) of non-treated grafts and 25% (9/36)
of grafts which had been treated with melatonin,
were recovered. However, this difference was not
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statistical significantly between the control and
treated groups (Table 1).
General observations and weight
of the testis graft
The places of transplantation were swollen and
became obvious within 9 weeks. However, more fre-
quently, recovered grafts showed a high degree of
abundant fat tissue (Fig. 1). In general, after 9 weeks
of transplantation, all recovered grafts in the treated
group grew larger in comparison to their weight be-
fore grafting (14–15 mg before grafting vs 55–61 mg
after grafting) (Table 1). Albeit, during 1–8 weeks of
transplantation the difference in mean weight of the
grafts was not statistically significant between the
non-treated and treated groups, whereas after
9 weeks, the mean weight of grafts in the treated
group (65.7 ± 3.5 mg) became greater than those
(52.4 ± 6.5 mg) from the non-treated group.
Histological analysis of the testis graft
Cryopreservation affects neither the number of
surviving germ cells nor their capacity to colonise
the seminiferous tubules (Fig. 2B). However, in gen-
eral, histological analysis of testis grafts showed
various degrees of spermatogenesis process in the
seminiferous tubules, displaying from total atrophy
to full spermatogenesis progression of the semini-
ferous tubules (Fig. 2A, E). The majority of these atro-
phic tubules contained only A-spermatogonia cells
and no other type of germ cells were presented (Fig. 2E).
Moreover, the kinetics of spermatogenic progression
were more marked in the treated group than in the
non-treated group.
In both groups the spermatocytes were the most
advanced germ cells observed after one week of trans-
plantation, which originally contained primitive gono-
cytes as the only sort of germ cell (Fig. 2C). Further-
more, the complete kinetics of spermatogenic pro-
gression was observed in the neonatal mouse testis
grafts within 9 weeks (Fig. 2D). A dilation of the lu-
Figure 1. Representative micrograph of subcutaneous site of testis
graft in host mice. Note the presence of the revascularisation sur-
rounding the transplant location to provide enough blood to the graft.
A
Table 1. Graft weights [mg], number of surviving grafts, mean percentage of damaged seminiferous tubules, thickness
of the seminiferous tubules [mm], and thickness of the germinal epithelium [mm] in both treated(T)/no-treated (N)
groups, 1–9 weeks after grafting of testis and treatment of the host mice with melatonin (20 mg/kg/day); values are
mean ± SD
Weeks Graft Graft Damaged Seminiferous Germinal
weight [mg] survive (N) tubules (%) tubules [mm] epithelium [mm]
T N T N T N T N T N
1 20.6 ± 2.5 19.8 ± 3.5 (36/29) (36/24) 51 ± 0.3 71 ± 0.3 65.3 ± 2.9 55.3 ± 5.9 5.6 ± 0.8 5.4 ± 0.9
2 25.4 ± 3.9 21.4 ± 2.9 (36/25) (36/20) 50 ± 2 69 ± 4 96.7 ± 3.9 76.7 ± 7.4 20.4 ± 1.3 14.9 ± 3.2
3 29.7 ± 3.3 25.9 ± 3.7 (36/26) (36/20) 49 ± 4 66 ± 3 128.7 ± 5.7 99.3 ± 9.5 27.9± 3.5 19.8 ± 3.9
4 37.7 ± 4.5 31.7 ± 5.1 (36/21) (36/19) 48 ± 6 69 ± 5 168.7 ± 6.4 139.5 ± 7.9 37.5 ± 5.3 29.3 ± 5.4
5 38.4 ± 3.7 32.1 ± 2.5 (36/13) (36/12) 45 ± 5 61 ± 7 209.9 ± 9.7 168.3 ± 9.1 57.5 ± 3.5 41.9 ± 3.9
6 49.9 ± 3.9 42.9 ± 3.6 (36/17) (36/11) 32 ± 6 59 ± 5 287.5 ± 7.5 219.8 ± 11.4 63.4 ± 9.5 47.3 ± 5.7
7 55.4 ± 4.6 45.4 ± 4.9 (36/19) (36/13) 31 ± 7 56 ± 8 309.3 ± 13.6 274 ±13.9 68.4 ± 11.5 51.7 ± 5.3
8 59.4 ± 7.5 51.7 ± 3.5 (36/10) (36/9)  34 ± 8 57 ± 5 279.7 ± 19.7 204 ± 19.3 64.3 ±13.5 45.5 ± 7.8
9 65.7 ± 3.5 52.4 ± 6.5 (36/9) (36/8) 38 ± 5 56 ± 6 297.3 ±13.3 192.1 ± 11.8 62.4 ± 9.8 41.9 ± 6.9
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Figure 2. Representative TUNEL-stained sections of vitrified-thawed testis graft from melatonin-treated and non-treated groups during the
examined weeks; A. TUNEL staining of testis graft sections from the treated group showing a seminiferous tubule with normal morpholo-
gy and low apoptosis germ cells at nine weeks after transplantation; B. TUNEL staining of vitrified-thawed neonate testis (six-day-old
mice) showing a seminiferous cord with normal morphology and low apoptosis primordial germ cells (PGC) before transplantation;
C. TUNEL staining of testis graft sections from the non-treatment group showing a seminiferous tubule with abnormal morphology and
high apoptotic cells (brown cells) at 9 weeks after transplantation; D. TUNEL staining of testis graft sections from the treated group at
9 weeks after transplantation. Note that the regions contain elongated spermatid in healthy seminiferous tubule; E. TUNEL staining of tes-
tis graft sections from the non-treated group showing that atrophied tubules containing just A-spermatogonia cells and did not have any
type of healthy germ cells at 9 weeks after transplantation; magnification 400 ¥ (B, C, D) and magnification 200 ¥ (A, E).
Figure 3. A. BrdU staining of testis graft sections from the melatonin-treated group, confirming the presence of cell proliferation at
9 weeks after transplantation; B. BrdU-staining of germ cells in the seminiferous tubule; magnification 400 ¥ (A) and 1000 ¥ (B).
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men accompanied by a disorganised epithelium and
premature sloughing of postmeiotic germ cells was
higher in the non-treated group (Fig. 2E). In some
testis grafts, especially in those that had a well sper-
matogenic progression, a morphologically normal
appearance of interstitial space with interstitial cells
and peritubular cells was observed (Fig. 2A). How-
ever, melatonin administration could be improve the
light microscopic morphology of interstitial tissue of
the testis grafts.
Seminiferous tubules of the testis grafts
An outline of damaged tubule number, thickness
of the seminiferous tubule, and germinal epithelium
illustrated in histological sections of testis is shown in
Table 1. Overall, the mean proportion of the number
of damaged seminiferous tubules throughout the
grafting days in each histological section of testis graft
was lower in the treated group (42%) than in the non-
treated group (62.6%). The mean proportion of the
thickness of seminiferous tubules throughout the graft-
ing days was larger in the treated group in compari-
son to the non-treated group (204.8 µm vs 158.8 µm;
p > 0.001). In fact, the mean proportion of the thick-
ness of the germinal epithelium was significantly dif-
ferent between the controls (33 µm) and the treated-
grafted testis (45.2 µm; p > 0.05).
TUNEL-positive apoptotic changes and
cell proliferative activity of the testis grafts
An outline of the relative percentage of cell apo-
ptosis (TUNEL assay) and proliferation (Brdu assay)
in germ cells of the testis is shown in Table 2. As indi-
cated by the persistence Brdu-positive cells in frozen-
grafted tissue (Fig. 3), spermatogonial cells were able
to survive after cryopreservation and grafting for
9 weeks. However, our data from TUNEL-positive apop-
totic cells revealed a significant loss of spermatogonia
after freezing and grafting of testis (Fig. 2A–E). Over-
all, their number was lower in the treated group when
compared with the non-treated group (35.7% vs 50%
per tubule respectively, p ≥ 0.001). Indeed, 51.8% of
spermatogonia continued to proliferate after freezing
and grafting in the treated group, compared to (36.4%,
p ≥ 0.001) in the non-treated group. Most of the
apoptotic cells were located along the base of the semi-
niferous tubules, which were identified as pachytene
spermatocytes (Fig. 2C).
DISCUSSION
The conservation of male gonad and gamete
by transplantation would spread out the applica-
bility of this merits model. The successful freez-
ing of spermatozoa that was collected from grafts
presents an opening approach towards the prac-
tical application of this method [18]. However, the
method of testis transplantation should be opti-
mised and made more accurate before being per-
formed on humans.
Our results confirmed that the germ cells in vitri-
fied and grafted testis tissue might help in survival
and retention of their capacity to initiate spermato-
genesis. Indeed, this observation suggests that us-
ing melatonin just after thawing vitrified testis tis-
sue and then continuing melatonin treatments dur-
Table 2. Relative percentage of TUNEL and BRDU positive per tubule in both treated and non-treated groups 1–9 weeks
after grafting of testes and treatment of the host mice with melatonin (20 mg/kg/day); values are mean ± SD
Weeks TUNEL positive (%) BRDU positive (%)
Treated group Non-treated group Treated group Non-treated group
1   57 ± 3.2     74± 4.6   20.5± 2.9 13.7 ± 3.1
2   49 ± 3.7    61 ± 5.3  29.3 ± 3.7 18.5 ± 2.9
3 39.7± 3.9 57.3 ± 2.8  31.5 ± 3.9    20 ± 2.3
4 33.5± 5.5 49.7 ± 5.3  40.9 ± 4.3 29.4 + 5.1
5 28.7± 4.9 37.9 ± 7.3  57.9 ± 5.6 41.2 ± 4.9
6 23.5± 3.3 35.7 ± 4.7  69.7 ± 3.7 49.6 ± 5.9
7 21.7± 4.5 39.9 ± 7.9  74.8 ± 5.9 53.6 ± 6.8
8 29.3± 4.7 43.9 ± 5.7  72.6 ± 7.5 51.6 ± 4.9
9 39.5± 6.5 51.3 ± 9.3  69.8 ± 5.9 49.7 ± 6.2
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ing transplantation is a feasible approach to better
maintain the potential of spermatogenesis kinetics,
and may serve as a promising method for graft pre-
servation.
However, detachment of the cells or fluid accu-
mulation was seen in all of the grafts, but this prob-
lem was more prominently observed in the grafts
that were collected from non-treated hosts. Yu et
al. [27] reported that fluid accumulation in the se-
miniferous tubules after grafting leads to degener-
ation of the graft. Therefore, melatonin may pro-
tect against this fluid accumulation.
This observation is in accordance with Li et al. [13],
who reported that melatonin, based on its low
molecular weight and high tissue penetration, pro-
vides superior antioxidant substance, especially in
solid tissues.
Our observations indicate that the first progres-
sion of spermatogenesis up to the level of sperma-
tocytes one week after transplantation was obviously
detected more in melatonin-treated grafts. There
was also a reduction in the number of seminiferous
tubules which only had A-spermatogonia in the
treated grafts.
The present study also showed that cryopreserva-
tion affects neither the number of surviving germ cells
nor their capacity to colonise the seminiferous tubules.
However, since cryopreservation, as performed here,
may have a negative impact on graft development,
further studies should be carried out with a focus on
processing the cryopreservation media containing
melatonin to optimise the outcome.
The melatonin-treated grafts showed a fast in-
crease in graft weight between 8 and 9 weeks after
grafting, and even the differentiation of sper-
matogonia and the progression of spermatogene-
sis up to the level of spermatid were significantly
higher than the grafted control samples.
Melatonin, as a well-known direct free radical
scavenger or a stimulator of several anti-oxidative
enzymatic systems, reduces the ability of reactive
oxygen species (ROS) to damage membrane poly-
unsaturated fatty acids [17]. In accordance with the
above-mentioned observations, we showed that me-
latonin significantly reduces the index cell apopto-
sis while significantly enhancing the activity of cell
proliferation. Thus, the efficacy of melatonin’s dual
function as both a direct ROS scavenger and an en-
hancer of proliferation cells of activity is a notable
and important point. NF-kappaB is central for the
overall immune response through its ability to acti-
vate gene coding for regulators of apoptosis and cell
proliferation [7]. The defining character activation of
iNOS after I/R enhances mucosal apoptosis in the rat
small intestine  [24] and the inhibition of iNOS ame-
liorate apoptosis after I/R [24]. Melatonin may con-
tribute to the down-regulation of NF-kappaB and sub-
sequently cause a decrease in iNOS expression [27].
Therefore, we expected that melatonin would subse-
quently ameliorate apoptosis.
There may be several reasons for the limited
development of cryopreserved testis tissue after
grafting. In order to allow cryoprotectant to pen-
etrate the tissue, small tissue fragments were pre-
pared. This procedure resulted in a limited num-
ber of seminiferous tubules in each preserved tis-
sue fragment and may have increased the variabil-
ity between fragments. It is also possible that re-
sidual cryoprotectant that remained in the frozen-
-thawed tissue after washing led to tissue toxici-
ty. Some damage to the tissue after freezing and
thawing cannot be avoided. As such, the frozen-
-thawed testis tissue may take longer to become
revascularised after grafting, and to initiate sper-
matogenesis, compared with fresh tissue. This may
explain why no spermatozoa were observed in the
allograft that was cryopreserved before transplan-
tation in the present study. This observation is in
agreement with a previous report that cryopreser-
vation delayed the initiation of spermatogenesis
in grafted testis tissue from rhesus monkeys [24].
Accordingly, Frederickx et al. [6] reported that the
spermatogonial stem cells may lose their functio-
nal capacity through cryopreservation regardless
of the suitable viability of the cell suspension ob-
served after thawing. In a recent study, Wyns et
al. [25] did not observe any changes in histologi-
cal morphology in thawed testis tissue compared
with fresh grafts. Immunohistological study be-
fore grafting, as evaluated in the present study,
or pre-grafting tissue morphology could not re-
veal the later difference in the effect of cryopro-
tectants on germ cell differentiation. Therefore,
previous studies and the present experiment con-
firm that transplantation is the only functional
assay to evaluate the developmental potential of
testis organ in vivo so far.
CONCLUSIONS
In conclusion, the data from this study indicates
that melatonin might improve the recovery of graft
and cellular function, reduce histological apoptosis,
and increase survival after reperfusion. As a pathophy-
siological explanation, melatonin significantly reduced
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apoptosis, while inducing proliferation of the cells.
These results suggest that melatonin may represent
a novel therapeutic approach in the prevention of is-
chaemia reperfusion injury after testis transplantation.
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